In the latest development, Janssen Vaccines & Prevention in Leiden, a subsidiary of American pharmaceutical company, Johnson & Johnson has started testing the potential coronavirus vaccine on humans in the US and Belgium.
Testing in the Netherlands
In a television programme Nieuwsuur, research leader Hanneke Schuitemaker said if everything goes well according to the plan, the testing will be expanded to the Netherlands, Germany, and Spain in September. ‘In September we will look at giving less of the vaccine and if the interval can be made shorter.’ The ongoing testing involves giving participants two vaccinations, eight weeks apart.